182HO01060 HUSTLE

Print/PDF
Registration Name AOT SPARTACUS HUSTLE-ET
Registration Number HO840003203571034
Primary NAAB Code 182HO01060
Secondary Code(s) 551HO04829, 151HO04829
Status Active AI Sire
Controller Name Genes Diffusion (2139)
Date of Birth 1/4/2020
aAa -
DMS -
GFI 12.6%
Genetic Codes * TP TL TD TC TR TV TY
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HMWT
Sire K-STYLE TARINO SPARTACUS-ET
MGS PROGENESIS FABULOUS-ET
Beta Casein -
Kappa Casein -
Beta Lactoglobulin -
INDEXES
NM$ 167, 81% R CM$ 177
NM Percentile 23% FM$ 140
GTPI 2862 GM$ 251
PRODUCTION TRAITS
307 Dtrs 76 herds 6 % US 90% R
Milk 495 Fat, % 26 , +0.02%
SCS 3.21, 89% R Protein, % 25 , +0.03%
Feed Saved 43 , 49% R Milking Speed 7.44 , 68% R
Health & Fertility
Productive Life -0.8      81% R Mastitis -2.5      77% R
Heifer Livability -0.7       60% R Metritis -1.2      74% R
Livability -4.6      76% R D. Abom -0.5      76% R
DPR 2.1      80% R Ketosis -0.7      73% R
HCR 2.6      78% R R. Placenta -1.6      74% R
FSC 8.9      79% R Milk Fever -0.3      67% R
CCR 2.8      79% R
SCR -        -
DIA -0.7      45% R
RSP -1.3      56% R
Calving Traits
Sire CE 0.9      76% R 623 Obs
Daughter CE 1.6      70% R 6 Obs, 357 Dtrs
Sire SB 3.0      66% R 190 Obs
Daughter SB 4.4      66% R 6 Obs, Dtrs
Gestation Length -2.6      85% R 6 Obs, 17 Dtrs
Early First Calving 6.1      78% R 1 Obs, 1 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
0 Dtrs 0 herds 82% R
PTA Type 1.46 UDC 1.38
HCC 1.09 BWC -0.02
FLC 0.65
Linear Traits
Stature 1.00
Tall
Strength 0.16
Strong
Body Depth 0.58
Deep
Dairy Form 1.12
Open
Rump Angle -0.41
Flat
Thurl Width 0.67
Wide
Rear Legs-Side View 0.19
Curved
Rear Legs-Rear View 0.50
Straight
Foot Angle 0.73
Steep
Feet & Legs Score 0.91
High
F.U. Attachment 1.90
Strong
Rear Udder Height 1.85
High
Rear Udder Width 1.17
Wide
Udder Cleft 0.93
Strong
Udder Depth 1.68
Shallow
Front Teat Placement 1.21
Close
Rear Teat Placement 1.15
Close
Teat Length -1.22
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO